Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system

American Journal of Health Behavior

Volumn 38, Issue 2, 2014, Pages 265-274

  Nides, Mitchell A ^a   Leischow, Scott J ^b   Bhatter, Meghna ^a   Simmons, Michael ^a  

^a Los Angeles Clinical Trials   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Electronic cigarette; Nicotine delivery; Smoking cessation

Indexed keywords

NICOTINE; NICOTINE GUM;

ADOLESCENT; ADULT; AGED; BLOOD; DRUG DELIVERY SYSTEM; DRUG EFFECTS; EVALUATION STUDY; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHYSIOLOGY; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SMOKING; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; TIME; TOBACCO; UNITED STATES; UTILIZATION; WITHDRAWAL SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DRUG DELIVERY SYSTEMS; FEMALE; HEART RATE; HUMANS; LOS ANGELES; MALE; MIDDLE AGED; NICOTINE; PATIENT SATISFACTION; QUESTIONNAIRES; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TOBACCO PRODUCTS; TOBACCO USE CESSATION; TOBACCO USE CESSATION PRODUCTS; YOUNG ADULT;

EID: 84888871245     PISSN: 10873244     EISSN: 19457359     Source Type: Journal    
DOI: 10.5993/AJHB.38.2.12     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. Current cigarette smoking among adults-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(44): 889-894.
2. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99: 29-38.
3. 2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update US Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008;53(9): 1217-1222.
4. King BA, Alam S, Promoff G, et al. Awareness and ever use of electronic cigarettes among U.S. Adults, 2010-2011 [published online ahead of print February 28, 2013]. Nicotine Tob Res. PMID: 23449421.
5. Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010 Apr;19(2): 98-103.
6. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19(8): 1945-1953.
7. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15(1): 267-270.
8. Farsalinos KE, Romagna G, Tsiapras D, et al. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health. 2013;10(6): 2500-2514.
9. Bullen C, Williman J, Howe C, et al. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health. 2013;13:210.
10. Caponnetto P, Russo C, Bruno CM, et al. Electronic cigarette: a possible substitute for cigarette dependence. Monaldi Arch Chest Dis. 2013;79(1): 12-19.
11. Caponnetto P, Auditore R, Russo C, et al. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013;10(2): 446-461.
12. Polosa R, Caponnetto P, Morjaria JB, et al. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011;11:786.
13. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction. 2012;107(8): 1493-1500.
14. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLOS One. 2013;8(6):e66317.
15. Marnett LJ, Cohen SM, Fukushima S, et al. Flavoring substances 26. Washington DC: Flavor and Extract Manufacturers Association. Available at: http://www. femaflavor.org/fema-gras%E2%84%A2-flavoring-substance- list. Accessed July 6, 2013.
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Addiction. 1991;86:1119-1127
17. Moyer TP, Charlson JR, Enger RJ, et al. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem. 2002;48(9): 1460-1471.
18. Shiffman S, Shadel WG, Niaura R, et al. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology. 2003;166: 343-350.
19. Niaura R, Sayette M, Shiffman S, et al. Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving. Addiction. 2005;100(11): 1720-1730.
20. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43: 289-294.
21. Kraiczi H, Hansson A, Perfekt R. Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy. Nicotine Tob Res. 2011;13(12): 1176-1182.
22. Benowitz NL, Goniewicz ML. The regulatory challenge of electronic cigarettes [published online ahead of print July 15, 2013]. JAMA. doi:10.1001/jama.2013.109501.
23. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes [published online ahead of print March 6, 2013]. Tob Control. doi:10.1136/tobaccocontrol- 2012-050859.